KRT88P and hepatocellular carcinoma: HBsAg(+), anti-HBc(+), but anti-HCV(−);rs2833856: associated with risk of HCC among patients with chronic HBV infection;rs4661093: associated with risk of HCC among patients with HBV-related decompensated cirrhosis.